(Q33499722)

27 July 2017

Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer (English)

1 reference

27 July 2017

1 reference

1 reference

1 reference

5

J H Beijnen

1 reference

27 July 2017

W W ten Bokkel Huinink

1

object named as

W W ten Bokkel Huinink

1 reference

27 July 2017

L J van Warmerdam

2

1 reference

27 July 2017

T J Helmerhorst

3

1 reference

27 July 2017

M C Schaefers

4

1 reference

27 July 2017

S Rodenhuis

6

1 reference

27 July 2017

1 April 1997

1 reference

27 July 2017

1 reference

27 July 2017

8

1 reference

27 July 2017

351-354

1 reference

27 July 2017

4

1 reference

Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer

27 July 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008219618331

7 January 2021

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008219618331

7 January 2021

Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008219618331

7 January 2021

Taxanes: a new class of antitumor agents.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008219618331

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008219618331

7 January 2021

Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008219618331

7 January 2021

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008219618331

7 January 2021

Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008219618331

7 January 2021

Identifiers

DOI

10.1023/A:1008219618331

1 reference

27 July 2017

1 reference